New platform brings four of the industry's most recognized direct-to-consumer brands together to ser

CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action l

AdaptHealth Corp. reported second quarter 2026 revenue of $740.3 million against consensus of roughl

AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio cha

AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The compan

[url="]Schall, Brown and Schwartz[/url] LLP (“SBS”), a national shareholder rights litigation fi

LOS ANGELES--(BUSINESS WIRE)---- $AHCO--AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fr

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”

NEW YORK--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after the Com

UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price ta

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ

Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (“AdaptHe

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf

AdaptHealth (NASDAQ: AHCO) reported second-quarter revenue growth in its continuing operations but l

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AdaptHe

AdaptHealth guided full-year 2026 adjusted EBITDA to $680 million to $730 million on May 5, 2026, an

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowe

AdaptHealth shares plunged after a deeply disappointing Q2, with a $1.07 loss and a $106 million rev

ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Holzer and Holzer, LLC is investigating whether AdaptHeal

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular se

U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22%

AdaptHealth Corp. (AHCO) Q2 2026 Earnings Call Transcript

AdaptHealth NASDAQ: AHCO reported second-quarter revenue growth in its continuing operations but low

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst co

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'

AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 b

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst co

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, wit

Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises

Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, i

Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory,

AdaptHealth disclosed a material cyberattack involving patient data and insurance billing passwords

Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating

Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the

Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises

UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price ta

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst co

AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $3.440 billion-$3.510 billion to $3.450 b

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and rais

Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowe

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.19 per share which missed the analyst co

Guidance for Fiscal Year 2026While fourth quarter 2025 Adjusted EBITDA was impacted by a legal settl

AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $846.289 million which beat the analyst consen